Bepotastine
Bepotastine (Talion, Bepreve) is a 2nd generation antihistamine. It was approved in Japan for use in the treatment of allergic rhinitis and urticaria/pruritus in July 2000 and January 2002, respectively. It is currently marketed in the United States under the brand-name Bepreve, by ISTA Pharmaceuticals.
Wikipage redirect
primaryTopic
Bepotastine
Bepotastine (Talion, Bepreve) is a 2nd generation antihistamine. It was approved in Japan for use in the treatment of allergic rhinitis and urticaria/pruritus in July 2000 and January 2002, respectively. It is currently marketed in the United States under the brand-name Bepreve, by ISTA Pharmaceuticals.
has abstract
Bepotastine (Talion, Bepreve) ...... reve, by ISTA Pharmaceuticals.
@en
ベポタスチン（Bepotastine）とは、選択的ヒスタミン ...... いる。また、点眼薬としての利用が検討されているところである。
@ja
ATC prefix
CAS number
125602-71-3
ChEBI
DrugBank
FDA UNII code
HYD2U48IAS
IUPAC name
4-[4-[(4-chlorophenyl)-pyridin-2-ylmethoxy]piperidin-1-yl]butanoic acid
@en
PubChem
thumbnail
Link from a Wikipage to an external page
Wikipage page ID
18,265,121
Wikipage revision ID
742,899,601
bioavailability
ChEMBL
ChemSpiderID
excretion
legal status
MedlinePlus
molecular weight
protein bound
routes of administration
smiles
Clc1cccCc3ncccc3
StdInChIKey
YWGDOWXRIALTES-UHFFFAOYSA-N
tradename
Verifiedfields
verifiedrevid
459,957,305
subject
hypernym
comment
Bepotastine (Talion, Bepreve) ...... reve, by ISTA Pharmaceuticals.
@en
ベポタスチン（Bepotastine）とは、選択的ヒスタミン ...... ンなどと比較すると、眠気を訴える患者が多いことが確認される。
@ja
label
Bepotastine
@en
ベポタスチン
@ja
